Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in

Kathryn Austgen1, Scott A Oakes, Don Ganem

  • 1Howard Hughes Medical Institute and G. W. Hooper Foundation, Departments of Microbiology and Medicine, University of California, San Francisco, California, USA.

Journal of Virology
|December 2, 2011
PubMed

Insights

Developing a mouse model for Kaposi

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Kaposi's sarcoma-associated herpesvirus (KSHV) infection is challenging to model in mice due to limited host range.
  • Understanding KSHV host range restriction is crucial for developing effective therapeutic strategies.
  • Previous studies indicate KSHV efficiently enters murine cells but fails to produce infectious virions.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying KSHV host range restriction in murine cells.
  • To identify cellular factors and viral processes that impede lytic KSHV replication in mice.

Main Methods:

  • Ectopic expression of KSHV RTA (replication and transcription activator) in murine cells.
  • Treatment of KSHV-infected murine cells with histone deacetylase inhibitors.
  • Genetic ablation of the mitochondrial apoptotic pathway in KSHV-infected murine cells.
  • Assessment of viral gene expression, DNA synthesis, and virion production.

Main Results:

  • Ectopic RTA expression resulted in limited viral gene expression and no virus production.
  • Histone deacetylase inhibitors induced aberrant viral transcription but not viral DNA synthesis or virion production.
  • Enhanced apoptosis was observed in aberrantly infected murine cells.
  • Ablation of the mitochondrial apoptotic pathway allowed viral DNA replication but not virion production.

Conclusions:

  • Multiple defects, occurring both before and after viral DNA synthesis, restrict lytic KSHV infection in murine cells.
  • Apoptosis plays a significant role in limiting KSHV replication in mice.
  • A mouse model for KSHV infection requires overcoming several barriers beyond initial entry and latency establishment.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...